# Preferences & Treatment Satisfaction Drivers in Rosacea Patients

> **NCT02602470** · — · COMPLETED · sponsor: **LEO Pharma** · enrollment: 206 (actual)

## Conditions studied

- Rosacea

## Interventions

- **DRUG:** Azelaic Acid Gel including: Finacea (Azelaic Acid Gel 15%, BAY39-6251)
- **DRUG:** Azelaic Acid Cream
- **DRUG:** Metronidazole gel
- **DRUG:** Metronidazole cream
- **DRUG:** Metronidazole Emulsion
- **DRUG:** Metronidazole Lotion
- **DRUG:** Brimonidine Tartrate Gel

## Key facts

- **NCT ID:** NCT02602470
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-08
- **Primary completion:** 2016-03-10
- **Final completion:** 2016-03-10
- **Target enrollment:** 206 (ACTUAL)
- **Last updated:** 2020-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02602470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02602470, "Preferences & Treatment Satisfaction Drivers in Rosacea Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02602470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*